Chronic fatigue syndrome in adolescence: Where to from here?

Archives of Pediatrics and Adolescent Medicine

Volumn 164, Issue 9, 2010, Pages 880-881

  Vollmer Conna, Ute ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ISOPROSTANE DERIVATIVE;

ADOLESCENT DISEASE; ADOLESCENT HEALTH; CHRONIC FATIGUE SYNDROME; EDITORIAL; HUMAN; KINESIOTHERAPY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; ADOLESCENT; COMPLICATION; FATIGUE SYNDROME, CHRONIC; MONONUCLEOSIS; MOTOR ACTIVITY; SLEEP;

ADOLESCENT; EXERCISE THERAPY; FATIGUE SYNDROME, CHRONIC; HUMANS; INFECTIOUS MONONUCLEOSIS; MOTOR ACTIVITY; OXIDATIVE STRESS; SLEEP;

EID: 77956358170     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2010.149     Document Type: Editorial

References (15)

1. Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009;124(1):189-193.
2. May M, Emond A, Crawley E. Phenotypes of chronic fatigue syndrome in children and young people. Arch Dis Child. 2010;95(4):245-249.
3. Working Group of the Royal Australasian College of Physicians. Chronic fatigue syndrome: clinical practice guidelines. Med J Aust. 2002;176:S17-S56.
4. Vollmer-Conna U, Aslakson E, White PD. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics. 2006; 7(3):355-364.
5. Aslakson E, Vollmer-Conna U, Reeves WC, White PD. Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue. Popul Health Metr. 2009;7:17.
6. White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry. 1998;173:475-481. (Pubitemid 28557128)
7. Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med. 2000;109(7):531-537.
8. Candy B, Chalder T, Cleare AJ, et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med. 2003;33(5):847-855. (Pubitemid 36874664)
9. Hickie I, Davenport T, Wakefield D, et al; Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575-580.
10. Huang Y, Katz BZ, Mears C, Kielhofner GW, Taylor R. Postinfectious fatigue in adolescents and physical activity. Arch Pediatr Adolesc Med. 2010;164(9): 803-809.
11. Candy B, Chalder T, Cleare AJ, Wessely S, White PD, Hotopf M. Recovery from infectious mononucleosis: a case for more than symptomatic therapy? a systematic review. Br J Gen Pract. 2002;52(483):844-851.
12. White PD, Sharpe MC, Chalder T, DeCesare JC, Walwyn R; PACE trial group. Protocol for the PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy. BMC Neurol. 2007;7:6.
13. Gordon B, Lubitz L. Promising outcomes of an adolescent chronic fatigue syndrome inpatient programme. J Paediatr Child Health. 2009;45(5):286-290.
14. Kennedy G, Khan F, Hill A, Underwood C, Belch JJF. Biochemical and vascular aspects of pediatric chronic fatigue syndrome. Arch Pediatr Adolesc Med. 2010; 164(9):817-823.
15. Puri BK, Agour M, Gunatilake KD, Fernando KA, Gurusinghe AI, Treasaden IH. An in vivo proton neurospectroscopy study of cerebral oxidative stress in myalgic encephalomyelitis (chronic fatigue syndrome). Prostaglandins Leukot Essent Fatty Acids. 2009;81(5-6):303-305.